Avohoidon tutkimussäätiö
Web28 Mar 2024 · We are proud to announce the successful seed funding round lead by Finnish deep-tech VC Voima Ventures and Avohoidon tutkimussäätiö. This funding goes to further development of StemSight's cell therapy product for limbal stem cell defiency. 31/08/2024. WebAvohoidon Tutkimussäätiö focuses on innovations that are based on scientific research and technologies backed by scientific breakthroughs. Search Crunchbase Start Free Trial
Avohoidon tutkimussäätiö
Did you know?
WebAvohoidon Tutkimussaatio General Information. Description. Avohoidon Tutkimussaatio is a venture capital fund, managed by Avohoidon Tutkimussäätiö. The fund is located in Finland and will invest in Europe. The fund will target healthcare technology systems, healthcare devices and supplies, and pharmaceuticals and biotechnology sectors. WebAvohoidon Tutkimussäätiö, Voima Ventures Request a demo to show more. Primary Industry Biotechnology Sub Industries Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development Website www.stemsight.fi Company Stage ...
WebAvohoidon Tutkimussäätiö. The Foundation makes direct investments to companies in healthcare, pharma and biotech sectors. Usually we invest on the first venture capital financing round as the lead investor. Private placement and secondary investments are also possible. We have a maximum of ten unlisted investments in our portfolio at a time. WebSuomen Teollisuuslääketieteen Edistämissäätiö, Avohoidon tutkimussäätiö and The Finnish Medical Foundation for their financial support in finalising this project. I also wish to express my warmest gratitude to all my good friends for their sympathy and compassionate interest in the work. The time spent in extra-
WebAvohoidon Tutkimussäätiö sr. Professional & Other Places. Espoo. Save. Share. Tips; Avohoidon Tutkimussäätiö sr. No tips and reviews. Log in to leave a tip here. Post. No … WebAvohoidon Tutkimussäätiö is a foundation acting as an independent charitable fund that makes direct investments in companies from healthcare, pharma and biotech sectors. Average round investment: 591k USD. Average number per year: 1.0. Distribution: 2024 (1) Portfolio companies: StemSight.
WebInformation on investments, active portfolio, exits, fund performance, dry powder and team for Avohoidon Tutkimussäätiö. Use the PitchBook Platform to explore the full …
Web18 Dec 2024 · Avohoidon Tutkimussäätiö is a leading life science investor with an evergreen fund that invests in breakthrough technologies and science-based innovation … the puzzle place weebusWeb14 Sep 2024 · Two of the latest successes were witnessed when StemSight and Sartar Therapeutics announced remarkable funding decisions. StemSight announced today that they have raised 500.000 euro seed … sign in frequency mfaWeb14 Sep 2024 · Koivusalo’s company, a spinout from Tampere University in Finland, is emblematic of this: it’s working on an off-the-shelf stem cell treatment that can regenerate cells in the eye’s cornea to cure certain types of blindness. StemSight has just secured €500k in funding from deep tech investors Voima Ventures and Avohoidon … the puzzle place tippy woo 123moviesWeb1 Nov 2024 · Avohoidon Tutkimussäätiö has made 2 investments. Their most recent investment was on Nov 1, 2024, when CurifyLabs raised €825K. Investments. Edit Investments Section. Number of Investments 2. Number of Lead Investments 1. the puzzle place train driving kidsWebUse the CB Insights Platform to explore Avohoidon Tutkimussäätiö's full profile. Avohoidon Tutkimussäätiö Portfolio Investments, Avohoidon Tutkimussäätiö Funds, … sign in freedom mobileWebAvohoidon Tutkimussäätiö. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your … sign in fox nationWebThe all female-founded company’s pioneering solutions have attracted praise from such prominent Finnish deep tech investors as Voima Ventures and Avohoidon Tutkimussäätiö. In late 2024, StemSight secured 500 000 euros in a seed funding round to further develop its cell therapy products. the puzzler a.j. jacobs